Swiecicki PL, Yilmaz E, Rosenberg AJ, Fujisawa T, et al. Reply to: Enfortumab Vedotin: A Promising Therapy for Head and Neck Cancer With Potential Links to Human Papillomavirus. J Clin Oncol 2025 Feb 19:JCO2500028. doi: 10.1200/JCO-25-00028.
PMID: 39970368